Free Trial

Verrica Pharmaceuticals (VRCA) Earnings Date, Estimates & Call Transcripts

$8.77
+0.07 (+0.80%)
(As of 05/21/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 13Estimated
Actual EPS
(Feb. 29)
-$0.48 Missed By -$0.01
Consensus EPS
(Feb. 29)
-$0.47
Skip Charts & View Estimated and Actual Earnings Data

VRCA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VRCA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Verrica Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.43)($0.43)($0.43)
Q2 20241($0.39)($0.39)($0.39)
Q3 20241($0.35)($0.35)($0.35)
Q4 20241($0.29)($0.29)($0.29)
FY 20244($1.46)($1.46)($1.46)

VRCA Earnings Date and Information

Verrica Pharmaceuticals last released its quarterly earnings data on February 29th, 2024. The reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.47) by $0.01. The business had revenue of $1.99 million for the quarter, compared to analyst estimates of $1.10 million. Verrica Pharmaceuticals has generated ($1.75) earnings per share over the last year (($1.75) diluted earnings per share). Earnings for Verrica Pharmaceuticals are expected to grow in the coming year, from ($1.62) to ($0.67) per share. Verrica Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.

Verrica Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/13/2024
(Estimated)
------- 
2/29/2024Q4 2023($0.47)($0.48)($0.01)($0.43)$1.10 million$1.99 million    
11/9/2023Q3 2023($0.22)($0.32)($0.10)($0.10)$1.12 million$2.92 million
8/8/2023Q2 2023($0.22)($0.24)($0.02)($0.24)-$0.18 million
5/9/2023Q1 2023($0.20)($0.15)+$0.05($0.15)-$0.04 million
3/6/2023Q4 2022($0.19)($0.14)+$0.05($0.14)-$0.07 million
11/7/2022Q3 2022($0.11)$0.03+$0.14$0.06$8.00 million$8.32 million
8/11/2022Q2 2022($0.36)($0.36)-($0.35)-$0.21 million
5/9/2022Q1 2022($0.59)($0.30)+$0.29($0.29)-$0.43 million
3/2/2022Q4 2021($0.48)($0.35)+$0.13($0.35)--
11/12/2021Q3 2021($0.51)($0.47)+$0.04($0.45)--
8/10/2021Q2 2021($0.41)($0.43)($0.02)($0.43)--
5/7/2021Q1 2021($0.35)($0.04)+$0.31($0.04)-$12.00 million
3/3/2021Q4 2020($0.42)($0.52)($0.10)($0.52)--
11/9/2020Q3 2020($0.43)($0.42)+$0.01($0.42)--
8/5/2020Q2 2020($0.45)($0.38)+$0.07($0.38)--
5/7/2020Q1 2020($0.38)($0.39)($0.01)($0.39)--
3/13/2020Q4 2019($0.30)($0.31)($0.01)($0.31)--
11/6/2019Q3($0.27)($0.24)+$0.03($0.24)--
8/7/2019Q2 2019($0.30)($0.28)+$0.02($0.28)--

Verrica Pharmaceuticals Earnings - Frequently Asked Questions

When is Verrica Pharmaceuticals's earnings date?

Verrica Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on VRCA's earnings history.

Did Verrica Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Verrica Pharmaceuticals (NASDAQ:VRCA) missed the analysts' consensus estimate of ($0.47) by $0.01 with a reported earnings per share (EPS) of ($0.48). Learn more on analysts' earnings estimate vs. VRCA's actual earnings.

How can I listen to Verrica Pharmaceuticals's earnings conference call?

The conference call for Verrica Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Verrica Pharmaceuticals's conference call transcript?

The conference call transcript for Verrica Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Verrica Pharmaceuticals generate each year?

Verrica Pharmaceuticals (NASDAQ:VRCA) has a recorded annual revenue of $5.12 million.

How much profit does Verrica Pharmaceuticals generate each year?

Verrica Pharmaceuticals (NASDAQ:VRCA) has a recorded net income of -$67 million. VRCA has generated -$1.75 earnings per share over the last four quarters.

What is Verrica Pharmaceuticals's EPS forecast for next year?

Verrica Pharmaceuticals's earnings are expected to grow from ($1.62) per share to ($0.67) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:VRCA) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners